Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Treatment of Grade B Esophagitis

PPI Treatment Duration

  • The American Gastroenterological Association recommends PPIs should be administered twice daily for at least 8-12 weeks before assessing histological response 1, 2, 3
  • Treatment duration of 8-10 weeks with PPI shows a response rate of 50.4%, while extending to 10-12 weeks increases response rate to 65.2% 4, 5
  • Longer treatment duration beyond 12 weeks has shown diminishing returns (44.1% response rate), possibly due to reduced patient adherence 4, 6

Assessment of Treatment Response

  • After the initial treatment period, endoscopy with biopsy should be performed to assess response, as symptoms may not always correlate with histological activity 1, 2
  • If symptoms recur while on treatment, repeat endoscopy is recommended for assessment and to obtain further histology 1, 2

Maintenance Therapy

  • For patients who achieve histological response, maintenance PPI therapy appears effective in preventing relapse 3, 5

Important Clinical Considerations

  • PPIs should be taken 30-60 minutes before meals for optimal efficacy 4, 6
  • When using PPI for esophagitis, it's essential to clearly communicate to patients and primary care providers that the medication is being prescribed for esophagitis treatment, not just for GERD 4, 6

Treatment Algorithm

  • Initial therapy: PPI twice daily for 8-12 weeks 2
  • Endoscopic assessment: Perform endoscopy with biopsy after 8-12 weeks to evaluate healing 1, 2
  • For refractory cases: Consider increasing PPI dose or adding other therapies 2, 4

REFERENCES